Currently out of the existing stock ratings of Zarak Khurshid, 5 are a BUY (45.45%), 1 are a SELL (9.09%), 5 are a HOLD (45.45%).
Analyst Zarak Khurshid, currently employed at WEDBUSH, has had 100% of price targets met with an average potential upside of 22.38%, reached in 443 days on average. Previously, Zarak Khurshid worked at JPMORGAN.
Zarak Khurshid has documented 22 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CERS, Cerus at 17-Dec-2015.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) on 5/30/2014. The price target of $14 was fulfilled within 5 days with a profit of $0.52 (3.86%), with a performance score of 7.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Mar-2026
$85
7 months 28 days ago
(24-Mar-2026)
51/51 (100%)
$15.41 (22.14%)
294
Buy Since 10-Apr-2025
$105
$-1714.87 (-94.23%)
$85
10 months 1 days ago
(20-Jan-2026)
3/3 (100%)
$2.65 (2.59%)
89
Buy Since 03-Aug-2021
$105
$-1714.87 (-94.23%)
$68
10 months 16 days ago
(05-Jan-2026)
10/10 (100%)
$3.39 (3.34%)
392
Buy Since 09-Jul-2021
$105
$-1714.87 (-94.23%)
$75
11 months 27 days ago
(25-Nov-2025)
16/16 (100%)
$3.87 (3.83%)
607
Buy Since 06-Nov-2024
$80
11 months 28 days ago
(24-Nov-2025)
2/2 (100%)
$32.58 (68.71%)
229
What Year was the first public recommendation made by Zarak Khurshid?